In:
Journal of Interventional Cardiology, Wiley, Vol. 11, No. s5 ( 1998-10)
Abstract:
Transmyocardial laser revascularization (TMR) is an experimental procedure for intractable angina that has demonstrated clinical benefit. The majority of patients who had TMR have significant reduction of angina. TMR has been performed exclusively by thoracic and cardiac surgeons using a handhold CO 2 laser device. The development of a prototype percutaneous device that delivers mid‐infrared laser energy (Ho:YAG) through a 9Fr coaxial catheter system recently has been reported. The long‐term benefits of this percutaneous approach is being defined in the context of the randomized PACIFIC Trial. The initial follow‐up suggested significant relief of angina in the majority of treated patients, and the results are likely to be equal or similar to those of surgical TMR. The safety data of percutaneous myocardial revascularization (PMR) with the CardioGenesis system showed exceedingly low morbidity and mortality.
Type of Medium:
Online Resource
ISSN:
0896-4327
,
1540-8183
DOI:
10.1111/joic.1998.11.issue-s5
DOI:
10.1111/j.1540-8183.1998.tb00204.x
Language:
English
Publisher:
Wiley
Publication Date:
1998
detail.hit.zdb_id:
2103585-4
Permalink